Moving from Challenges to Solutions
This annual oncology conference, 2022 Summit on Cancer Health Disparities (SCHD22), will feature lectures, panel discussions and debates among leaders across the spectrum of cancer care delivery. This conference will bring together oncology professionals, cancer disparity researchers, and other stakeholders to discuss the factors leading to cancer health disparities and ways to overcome the impact of these factors to optimize outcomes of cancer patients.
SCHD22 is an accredited continuing education activity (CME activity) that will foster collaborative interdisciplinary interactions and partnerships to stimulate the development of new research and clinical practices that reduce cancer health disparities and improve outcomes of the diverse patient population.
Oncologist and Hematologists
Oncology and Hematology Nurse Practitioners
Oncology and Hematology Physician Assistants
Oncology and Hematology Nurses
Oncology and Hematology Pharmacists
Oncology and Hematology Fellows/Residents
Oncology and Hematology Researchers
Others interested in cancer disparities
Identify drivers of cancer health disparities and review their impact on patients along the cancer continuum.
State the financial and physical barriers, review strategies to navigate these factors to optimize management of patients with cancer.
Incorporate evidence-based strategies to minimize the impact of specific drivers of inequity in the management of patients with cancer.
Describe challenges and develop novel approaches to improve participation of underrepresented communities in clinical trials.
Founder & PresidentBinaytara Foundation
Hematologist/OncologistVirginia Mason Cancer Institute
Clinical Director, Center to Eliminate Cancer DisparitiesThomas Jefferson University
Professorship of Breast Cancer Research, University of WashingtonFred Hutchinson Cancer Research Center
Global Cancer Care ProgramHarvard University
Consultant medical oncologist
Director of Medical OncologyMax cancer centre, New Delhi, India
Chairman, Precision Oncology Alliance, Caris Life Sciences
Adjunct Professor, University of South Carolina
Memorial Sloan Kettering Cancer Center, NY
Medical OncologistSkane University Hospital, Sweden
City of Hope
Medical Director, Clinical Trials
Chief, Section of GI Medical Oncology
Director, Arizona Clinical Trials Network
Head of Medical Oncology
Dubai Hospital, UAE
Co-Program Director, Cardiothoracic Imaging Fellowship
Associate Professor of Radiology
The Hospital of the University of Pennsylvania
Associate Professor, Investigational Cancer Therapeutics Department
Center Clinical Medical Director, Clinical Center for Targeted Therapy
The University of Texas MD Anderson Cancer Center.
OncoAlert is a network of Cancer Care professionals (Medical, Radiation & Surgical Oncologists, along with Cancer Scientists, Oncology nurses and patient advocates). They are a global network with the majority of their faculty coming from the United States and Europe, but they are quickly extending.
ecancer was founded in 2007 by two inspirational oncologists, Prof Gordon McVie and Prof Umberto Veronesi. They created ecancer.org as a free online platform which would allow everyone to share and benefit from new discoveries and developments. Every month ecancer supports tens of thousands of medical professionals worldwide to learn new skills, update their knowledge and improve the care for their patients with cancer.
The Binaytara Foundation (BTF) is a 501(c)3 non profit organization working to improve access to cancer care in the United States and other parts of the world.